Global Vaccines & Vaccination Summit & B2B
November 01-02, 2017 | Toronto, Canada
Sno Abstract Title Abstract Type Edit Delete
1 Universal viral vectors for prophylactic vaccines against infectious diseases and for therapeutic vaccines against persistent viral infections
Chil-Yong Kang
HTML | PDF | Add Speaker+ [1 ]
Keynote
2 The Brazilian national immunization program and its challenges for modernization and improvement
Ricardo Bordinhao
HTML | PDF | Add Speaker+ [1 ]
Keynote
3 Recent progress in human mucosal vaccine development: Role of mucosal immunity and mucosal microbiome in the outcome of vaccine effectiveness
Pearay L Ogra
HTML | PDF | Add Speaker+ [1 ]
Keynote
4 Feasibility of monitoring cell mediated immunity during vaccine trials
Magdalena Tary-Lehmann
HTML | PDF | Add Speaker+ [1 ]
Keynote
5 Measles vaccination: Threat from related veterinary viruses and need for continued vaccination post measles eradication
S Louise Cosby
HTML | PDF | Add Speaker+ [1 ]
Keynote
6 Community engagement in HIV vaccine research as a treatment strategy among men who have sex with men (MSM)
Kelvin Owange Otieno
HTML | PDF | Add Speaker+ [1 ]
Keynote
7 Colon cancer stem cell-based vaccine reduces efficiently both tumour growth and cancer stem cell subpopulation in a mouse colon carcinoma model
Jun Dou
HTML | PDF | Add Speaker+ [1 ]
Keynote
8 Can mucosal immunity succeed where other systemic immune responses failed? Intranasal immunization using a NanostatTM platform technology protected against respiratory and sexually transmitted diseases in the appropriate animal challenge models
Ali Fattom
HTML | PDF | Add Speaker+ [1 ]
Keynote
9 Autoimmunity in breast carcinogenesis: Implications for vaccination in solid tumors
Felix Fernandez Madrid
HTML | PDF | Add Speaker+ [1 ]
Keynote